Repoceuticals A/S
Public limited companyCVR 36494433HørsholmActive
Repoceuticals A/S is a public limited company, based in Hørsholm, active in manufacture of pharmaceutical preparations, founded in 2015. The company made a loss in both 2024 and 2025, most recently DKK 6.2bn. Equity grew to DKK 6.2bn in 2025. Gross profit is higher than that of 82% of the companies in the industry in the database.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss grew: from DKK 6.3m to DKK 6.2bn (2024 → 2025).
- Equity rose 130,227% (2024 → 2025), to DKK 6.2bn.
Management and owners, last 24 months
- New in management: Henrik Bulskov (chair of the board, 22/10/2025) and Troels Peter Troelsen (board member, 22/10/2025).
- Stepped down: Preben Møllegaard Grundtvig (board member, 27/06/2025), Henrik Bulskov (board member, 21/10/2025) and Troels Peter Troelsen (chair of the board, 21/10/2025) (+2).
- No longer registered as owner: Bregnerødvej Auto ApS (06/11/2024) and TT 1919 ApS (13/12/2024).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 88,000 | – |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 88,000 | – |
| Operating profit (EBIT) | −1,201 | – | – | – | −5,084 | −4,879,106 | −95,876.8% |
| Profit before tax | −1,323 | −5,838 | −5,042 | −5,894 | −6,738 | −6,527,163 | −96,777.9% |
| Net profit | −859 | −4,402 | −3,829 | −5,200 | −6,275 | −6,228,938 | −99,173.1% |
| Total assets | 9,885 | 14,335 | 9,491 | 9,686 | 12,056 | 10,301,646 | +85,349.7% |
| Equity | 5,183 | 12,041 | 8,300 | 2,838 | 4,792 | 6,245,088 | +130,227.3% |
| Liabilities | – | – | 1,190 | 6,848 | 7,264 | 4,056,557 | +55,745.1% |
| Cash and cash equivalents | 132 | 5,601 | 1,207 | 1,152 | 13 | 80,960 | +638,536.9% |
| Average number of employees | 1 | – | – | – | – | – | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 08/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 28/06/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 20/06/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 02/06/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 02/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 03/02/2022 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
59 companies in the databaseComparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.
Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 339of 69,742 Better than 100% | No. 31of 69,964 Better than 100% |
| Same industry and fewer than 20 employees37 companies in the comparison | No. 1of 36 Better than 100% | No. 1of 37 Better than 100% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 375of 33,588 Better than 99% | No. 11of 33,687 Better than 100% |
| All companies of type A/S18,025 companies in the comparison | No. 1,761of 17,786 Better than 90% | No. 87of 18,024 Better than 100% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of pharmaceutical preparations- Repoceuticals A/SDKK 88m
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Repoceuticals A/S−DKK 6.2bn
- Novo Nordisk A/SDKK 102.4bn
- H. Lundbeck A/SDKK 3.2bn
- Repoceuticals A/SDKK 6.2bn
- Novo Nordisk A/SDKK 194bn
- H. Lundbeck A/SDKK 24.9bn
- Repoceuticals A/S2
- Novo Nordisk A/S27,279
- H. Lundbeck A/S2,261
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Clinicuro ApS5%
- Niels Erik Jespersen Holding ApS10%
- PM Group Holding ApS5%
- Anpartsselskabet af 11.11.201910%
- Beier Holding ApS10%
- Dmz Holding ApS15%
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Torsten Bjørn | Director | 20/04/2016 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Christian Vinding Thomsen | Board member | 22/06/2021 |
| Charlotte Pahl | Board member | 22/06/2021 |
| Henrik Bulskov | Chair of the board | 22/10/2025 |
- Auditor
- Grant Thornton, Godkendt Revisionspartnerselskab
- Founders
- Mll-001 ApS
Former management (10)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Henrik Lasse Lindblad | Director | 16/01/2015 | 20/04/2016 |
| Troels Peter Troelsen | Board member | 18/06/2019 | 12/06/2024 |
| Preben Møllegaard Grundtvig | Board member | 18/06/2019 | 27/06/2025 |
| Henrik Bulskov | Board member | 18/06/2019 | 21/10/2025 |
| Sigbjørn Georg Nielsen Kjærgård | Chair of the board | 18/06/2019 | 12/06/2024 |
| Nete Søgaard Poulsen | Board member | 18/06/2019 | 24/05/2023 |
| Charlotte Pahl | Deputy board member | 18/06/2019 | 21/06/2021 |
| Troels Peter Troelsen | Chair of the board | 13/06/2024 | 21/10/2025 |
| Sigbjørn Georg Nielsen Kjærgård | Board member | 13/06/2024 | 27/06/2025 |
| Troels Peter Troelsen | Board member | 22/10/2025 | 28/05/2026 |
Signing rule: Selskabet tegnes af en direktør og formanden for bestyrelsen eller af den samlede bestyrelse.
Address and production units
1 active production unitsSlotsmarken 12
2970 Hørsholm
Hørsholm Municipality · Postcode 2970
Other companies at the address (3)
- Finansmanagement ApSNon-financial holding companies
- Planner365 ApSComputer programming activities
- Reponex Pharmaceuticals A/SManufacture of pharmaceutical preparations
| Production unit | Address | Employees | P number |
|---|---|---|---|
| REPOCEUTICALS A/S | Slotsmarken 12, 1. th, 2970 Hørsholm | 2 | 1020077049 |
Purpose
Selskabets formål er at udvikle repositionerede lægemidler samt dermed beslægtede aktiviteter
The purpose is quoted from the register in Danish.
Changes year by year
101 registered events20262 changesaccounts 1 · management 1
- AccountsAnnual report for 2025 published
- ManagementTroels Peter Troelsen stepped down as board member
20257 changesmanagement 6 · accounts 1
- ManagementTroels Peter Troelsen appointed board member
- ManagementHenrik Bulskov appointed chair of the board
- ManagementTroels Peter Troelsen stepped down as chair of the board
- ManagementHenrik Bulskov stepped down as board member
- AccountsAnnual report for 2024 published
- ManagementSigbjørn Georg Nielsen Kjærgård stepped down as board member
- ManagementPreben Møllegaard Grundtvig stepped down as board member
202411 changesownership 6 · accounts 1 · management 4
- OwnershipTT 1919 ApS is no longer registered as owner
- OwnershipBREGNERØDVEJ AUTO ApS is no longer registered as owner
- AccountsAnnual report for 2023 published
- OwnershipDMZ HOLDING ApS registered as owner (15%)
- ManagementTroels Peter Troelsen appointed chair of the board
- ManagementSigbjørn Georg Nielsen Kjærgård appointed board member
- OwnershipDMZ HOLDING ApS is no longer registered as owner
- ManagementTroels Peter Troelsen stepped down as board member
- ManagementSigbjørn Georg Nielsen Kjærgård stepped down as chair of the board
- OwnershipDMZ HOLDING ApS registered as owner (5%)
- OwnershipFINANSMANAGEMENT ApS is no longer registered as owner
20234 changesownership 2 · accounts 1 · management 1
- OwnershipFINANSMANAGEMENT ApS registered as owner (5%)
- OwnershipMLL-001 ApS is no longer registered as owner
- AccountsAnnual report for 2022 published
- ManagementNete Søgaard Poulsen stepped down as board member
20222 changesaccounts 2
- AccountsAnnual report for 2021 published
- AccountsAnnual report for 2020 published
202110 changesownership 6 · capital 1 · management 3
- OwnershipVULKAN INVEST ApS is no longer registered as owner
- OwnershipBeier Holding ApS registered as owner (10%)
- OwnershipBeier Holding ApS is no longer registered as owner
- CapitalShare capital changed from 560,000 DKK to 896,135 DKK
- OwnershipAnpartsselskabet af 11.11.2019 registered as owner (10%)
- ManagementCharlotte Pahl appointed board member
- ManagementChristian Vinding Thomsen appointed board member
- ManagementCharlotte Pahl stepped down as deputy board member
- OwnershipMLL-001 ApS registered as owner (10%)
- OwnershipMLL-001 ApS is no longer registered as owner
20202 changesownership 2
- OwnershipPM Group Holding ApS registered as owner (5%)
- OwnershipPM Group Holding ApS is no longer registered as owner
201918 changesownership 9 · name 1 · capital 2 · management 6
- OwnershipStøckler Invest ApS is no longer registered as owner
- NameName changed from REPOCEUTICALS ApS to REPOCEUTICALS A/S
- CapitalShare capital changed from 80,000 DKK to 560,000 DKK
- ManagementCharlotte Pahl appointed deputy board member
- ManagementTroels Peter Troelsen appointed board member
- ManagementPreben Møllegaard Grundtvig appointed board member
- ManagementHenrik Bulskov appointed board member
- ManagementNete Søgaard Poulsen appointed board member
- ManagementSigbjørn Georg Nielsen Kjærgård appointed chair of the board
- OwnershipBeier Holding ApS registered as owner (5%)
- CapitalShare capital changed from 50,000 DKK to 80,000 DKK
- OwnershipNIELS ERIK JESPERSEN HOLDING ApS registered as owner (10%)
- OwnershipPM Group Holding ApS registered as owner (10%)
- OwnershipKJELDSBJERGGAARD ApS is no longer registered as owner
- OwnershipPM Group Holding ApS is no longer registered as owner
- OwnershipNIELS ERIK JESPERSEN HOLDING ApS is no longer registered as owner
- OwnershipTT 1919 ApS registered as owner (5%)
- OwnershipTT 1919 ApS is no longer registered as owner
201812 changesownership 12
- OwnershipKJELDSBJERGGAARD ApS registered as owner (5%)
- OwnershipLMJ Trading & Import ApS is no longer registered as owner
- OwnershipTT 1919 ApS registered as owner (10%)
- OwnershipBeier Holding ApS is no longer registered as owner
- OwnershipTT 1919 ApS is no longer registered as owner
- OwnershipPM Group Holding ApS registered as owner (5%)
- OwnershipSAX FINANS ApS is no longer registered as owner
- OwnershipNIELS ERIK JESPERSEN HOLDING ApS registered as owner (5%)
- OwnershipSAX FINANS ApS registered as owner (10%)
- OwnershipMLL-001 ApS registered as owner (20%)
- OwnershipSAX FINANS ApS is no longer registered as owner
- OwnershipMLL-001 ApS is no longer registered as owner
201711 changesownership 11
- OwnershipBeier Holding ApS registered as owner (5%)
- OwnershipTT 1919 ApS registered as owner (5%)
- OwnershipSAX FINANS ApS registered as owner (33.33%)
- OwnershipScandinavian Shares Holding AB is no longer registered as owner
- OwnershipLMJ Trading & Import ApS registered as owner (5%)
- OwnershipMLL-001 ApS registered as owner (15%)
- OwnershipMLL-001 ApS is no longer registered as owner
- OwnershipScandinavian Shares Holding AB registered as owner (20%)
- OwnershipMorten Peter Friis is no longer registered as owner
- OwnershipMorten Peter Friis registered as owner (25%)
- OwnershipJARO HOLDING ApS is no longer registered as owner
201611 changesownership 9 · management 2
- OwnershipBREGNERØDVEJ AUTO ApS registered as owner (5%)
- OwnershipStøckler Invest ApS registered as owner (10%)
- OwnershipTT 1919 ApS is no longer registered as owner
- OwnershipCLINICURO ApS registered as owner (5%)
- OwnershipCLINICURO ApS is no longer registered as owner
- OwnershipCLINICURO ApS registered as owner (15%)
- OwnershipSAX FINANS ApS is no longer registered as owner
- OwnershipCLINICURO ApS is no longer registered as owner
- OwnershipTT 1919 ApS registered as owner (10%)
- ManagementTorsten Bjørn appointed director
- ManagementHenrik Lasse Lindblad stepped down as director
201511 changesownership 9 · founded 1 · management 1
- OwnershipSAX FINANS ApS registered as owner (5%)
- OwnershipJARO HOLDING ApS registered as owner (25%)
- OwnershipASBA CONSULTING ApS is no longer registered as owner
- OwnershipJARO HOLDING ApS is no longer registered as owner
- OwnershipVULKAN INVEST ApS registered as owner (5%)
- OwnershipMLL-001 ApS registered as owner (25%)
- OwnershipCLINICURO ApS registered as owner (10%)
- OwnershipASBA CONSULTING ApS registered as owner (15%)
- OwnershipJARO HOLDING ApS registered as owner (25%)
- FoundedRegistered as REPOCEUTICALS ApS
- ManagementHenrik Lasse Lindblad appointed director
Related companies
Same industry in Hørsholm
- Afyx Therapeutics A/S13 employees
- Reponex Pharmaceuticals A/S2 employees
Same people in management
- Abacus Medicine A/Svia Troels Peter Troelsen
- Avis Budget Denmark A/Svia Christian Vinding Thomsen
- KT Stålindustri A/Svia Christian Vinding Thomsen
- Cityfys A/Svia Troels Peter Troelsen
- Benny Johansen & Sønner A/Svia Troels Peter Troelsen
- Intervare A/Svia Troels Peter Troelsen
Largest in the industry
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Leo Pharma A/SDKK 8.2bn
- Alk-abelló A/SDKK 4.2bn
- Bavarian Nordic A/SDKK 3bn
- Pharmacosmos A/SDKK 1.6bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.